| scholarly article | Q13442814 |
| P2093 | author name string | Yi Wang | |
| Ran Liu | |||
| Xiaobo Li | |||
| Wei Guo | |||
| Yuan Peng | |||
| Enchun Pan | |||
| Lihong Yin | |||
| Yuepu Pu | |||
| P2860 | cites work | Esophageal Cancer | Q56209683 |
| Lipid map of the mammalian cell | Q57075744 | ||
| The modulation of choline phosphoglyceride metabolism in human colon cancer | Q71753270 | ||
| Phospholipid distribution in murine mammary adenocarcinomas induced by activated neu oncogene | Q74277327 | ||
| Changes in electric charge and phospholipids composition in human colorectal cancer cells | Q81139923 | ||
| 1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma | Q82837384 | ||
| S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells | Q24646539 | ||
| Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression | Q24654019 | ||
| HMDB: a knowledgebase for the human metabolome | Q24655295 | ||
| Phosphoinositides in cell regulation and membrane dynamics | Q27861051 | ||
| Principles of bioactive lipid signalling: lessons from sphingolipids | Q28265743 | ||
| Advances in structure elucidation of small molecules using mass spectrometry | Q28743720 | ||
| METLIN: a metabolite mass spectral database | Q29614808 | ||
| Sphingosine-1-phosphate: an enigmatic signalling lipid | Q29620563 | ||
| Tumour phospholipid metabolism | Q33179622 | ||
| Metabolomics: available results, current research projects in breast cancer, and future applications. | Q34628323 | ||
| Metabolic fingerprinting as a diagnostic tool. | Q34699756 | ||
| Phospholipid metabolites as indicators of cancer cell function | Q35538301 | ||
| Choline phospholipid metabolism: a target in cancer cells? | Q35549481 | ||
| Metabolomics | Q36275142 | ||
| Phosphatidic acid- and phosphatidylserine-binding proteins | Q36453653 | ||
| Sphingolipids as modulators of cancer cell death: potential therapeutic targets | Q36574107 | ||
| Dissecting lipid raft facilitated cell signaling pathways in cancer | Q37047889 | ||
| Lipid signalling in disease. | Q37064018 | ||
| Lipid-based biomarkers for cancer | Q37537916 | ||
| The role of metabolites and metabolomics in clinically applicable biomarkers of disease. | Q37800811 | ||
| Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance | Q37808219 | ||
| Challenges and opportunities of metabolomics | Q37950296 | ||
| Metabolomics in the fields of oncology: a review of recent research | Q37986476 | ||
| Recent advances in metabolomics in oncology | Q37990967 | ||
| Serum metabolomics as a novel diagnostic approach for disease: a systematic review | Q38014695 | ||
| Metabolomics in the developing human being | Q38049380 | ||
| Lipidomic approach to identify patterns in phospholipid profiles and define class differences in mammary epithelial and breast cancer cells. | Q39450910 | ||
| Disruption of sphingosine 1-phosphate lyase confers resistance to chemotherapy and promotes oncogenesis through Bcl-2/Bcl-xL upregulation | Q39771348 | ||
| Membrane phosphatidylserine regulates surface charge and protein localization | Q40026492 | ||
| Cell cycle regulation of membrane phospholipid metabolism. | Q41029982 | ||
| Coordination of membrane phospholipid synthesis with the cell cycle | Q41488260 | ||
| Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. | Q43292555 | ||
| Worldwide esophageal cancer collaboration | Q44185301 | ||
| Effects of cell membrane phospholipid level and protein kinase C isoenzyme expression on hepatic metastasis of colorectal carcinoma | Q45020264 | ||
| Systems biology: Metabonomics | Q47647280 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | esophageal squamous cell carcinoma | Q108442577 |
| metabolomic profiling | Q118125815 | ||
| P304 | page(s) | 8899-8911 | |
| P577 | publication date | 2013-04-24 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform | |
| P478 | volume | 14 |
| Q91710754 | 1H-NMR spectroscopy identifies potential biomarkers in serum metabolomic signatures for early stage esophageal squamous cell carcinoma |
| Q91974787 | A systematic review of metabolomic profiling of gastric cancer and esophageal cancer |
| Q28079507 | Advances in Lipidomics for Cancer Biomarkers Discovery |
| Q94463833 | Blood-based biomarkers for early detection of esophageal squamous cell carcinoma |
| Q34072418 | DADS suppresses human esophageal xenograft tumors through RAF/MEK/ERK and mitochondria-dependent pathways |
| Q36130496 | Identification of Serum Markers of Esophageal Adenocarcinoma by Global and Targeted Metabolic Profiling |
| Q49926402 | Integrative Pathway Analysis of Genes and Metabolites Reveals Metabolism Abnormal Subpathway Regions and Modules in Esophageal Squamous Cell Carcinoma |
| Q34318206 | Metabolomics for biomarker discovery in gastroenterological cancer |
| Q44951888 | Metabolomics for the masses: The future of metabolomics in a personalized world |
| Q50090010 | Metabolomics toward personalized medicine. |
| Q50800787 | Monitoring of changes in lipid profiles during PLK1 knockdown in cancer cells using DESI MS. |
| Q38149245 | Novel diagnostic and prognostic biomarkers in esophageal cancer |
| Q31030138 | Pathway, in silico and tissue-specific expression quantitative analyses of oesophageal squamous cell carcinoma genome-wide association studies data |
| Q36045221 | Phospholipids as cancer biomarkers: Mass spectrometry-based analysis |
| Q44497536 | Phospholipids profiling and outcome of peritoneal dialysis patients |
| Q85390770 | Rapid LC-MRM-MS assay for simultaneous quantification of choline, betaine, trimethylamine, trimethylamine N-oxide, and creatinine in human plasma and urine |
| Q53105672 | Serum miR-1297: a promising diagnostic biomarker in esophageal squamous cell carcinoma. |
| Q38692340 | Volatile organic compounds as new biomarkers for colorectal cancer: a review |
Search more.